Compounds > azacitidine

azacitidine and Adenoma, Prostatic

azacitidine has been researched along with Adenoma, Prostatic in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (5.56)	18.2507
2000's	10 (55.56)	29.6817
2010's	7 (38.89)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baptista, T; Costa, VL; Henrique, R; Jerónimo, C; Martins, AT; Morais, A; Oliveira, AI; Oliveira, J	1
Dehghani, M; Kianpour, S; Mokarram, P; Monabati, A; Mostafavi-Pour, Z; Torabinejad, S	1
Han, B; Lu, N; Ma, Q; Qi, M; Tan, W; Wang, L; Zhang, L	1
Chang, I; Dahiya, R; Deng, G; Fukuhara, S; Hashimoto, Y; Imai-Sumida, M; Kato, T; Majid, S; Mitsui, Y; Nakajima, K; Saini, S; Shiina, H; Shiina, M; Tanaka, Y; Wong, DK; Yamamura, S	1
Califano, JA; Henrique, R; Jeronimo, C; Kim, MS; Lee, J; Liu, JW; Moon, CS; Nagpal, JK; Ostrow, KL; Sidransky, D; Sun, W; Trink, B; Van Criekinge, W; Zhou, S	1
Du, J; Gong, J; Guan, M; Hu, J; Hu, T; Jiang, H; Liu, W; Lu, Y; Sun, C; Sun, Y	1
Kim, EJ; Kim, IY; Kim, SK; Kim, WJ; Kim, YJ; Kim, YW; Yoon, HY	1
D'Alessandro, AM; Di Clemente, L; Di Pasquale, B; Dolo, V; Festuccia, C; Gravina, GL; Mancini, A; Marampon, F; Muzi, P; Ranieri, G	1
Hirokawa, Y; Matsuzaki, T; Shiraishi, T; Sugimura, Y; Suzuki, H; Takagi, A; Watanabe, M; Yamada, Y; Yamanaka, M; Yatani, R	1
Anast, JW; Bassett, WW; Carroll, PR; Dahiya, R; Enokida, H; Igawa, M; Kane, CJ; Kawahara, M; Kawakami, T; Li, LC; Nakagawa, M; Ogishima, T; Shiina, H; Terashima, M; Urakami, S; Verma, M	1
Bassett, WW; Breault, JE; Dahiya, R; Enokida, H; Fujime, M; Igawa, M; Kawakami, T; Li, LC; Ogishima, T; Ribeiro-Filho, LA; Shiina, H; Tabatabai, L; Terashima, M; Urakami, S	1
Dahiya, R; Enokida, H; Igawa, M; Kawakami, T; Li, LC; Nonomura, N; Ogishima, T; Okino, ST; Okuyama, A; Shiina, H; Tanaka, Y; Tokizane, T; Urakami, S	1
Guan, M; Popescu, NC; Soulitzis, N; Spandidos, DA; Zhou, X	1
Das, PM; Ferdinand, L; Gopisetty, G; Ramachandran, K; Reis, IM; Singal, R; Vanwert, J	1
Carvalho, AL; Cerveira, N; Costa, VL; Henrique, R; Hoque, MO; Jerónimo, C; Oliveira, J; Ribeiro, FR; Sidransky, D; Teixeira, MR	1
Chi, SG; deVere White, RW; Gumerlock, PH; Muenzer, JT	1
Akakura, K; Ichikawa, T; Igarashi, T; Ito, H; Kito, H; Nakayama, T; Sekita, N; Shiraishi, T; Suzuki, H; Toyota, M; Watanabe, M; Yoshie, O	1
Dahiya, R; Dharia, A; Li, LC; Nojima, D; Perinchery, G; Ribeiro-Filho, L; Yen, TS	1

Other Studies

18 other study(ies) available for azacitidine and Adenoma, Prostatic

Article	Year
Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer. BMC genomics, 2013, Dec-17, Volume: 14 Topics: Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidine; Cell Line, Tumor; CpG Islands; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Promoter Regions, Genetic; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Processing, Post-Translational	2013
Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer. Pathology oncology research : POR, 2015, Volume: 21, Issue:4 Topics: Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Cadherins; CpG Islands; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Integrin alpha4; Male; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	2015
Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation. The Prostate, 2015, Aug-01, Volume: 75, Issue:11 Topics: Adiponectin; Aged; Antimetabolites, Antineoplastic; Azacitidine; Cell Proliferation; China; DNA Methylation; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Male; Neoplasm Grading; Promoter Regions, Genetic; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Tumor Cells, Cultured	2015
Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer. Oncotarget, 2016, Aug-02, Volume: 7, Issue:31 Topics: Aged; Aged, 80 and over; Apoptosis; Azacitidine; Cell Line, Tumor; CpG Islands; Cytochrome P-450 CYP1A1; Decitabine; DNA Methylation; Enhancer Elements, Genetic; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfites; Tissue Array Analysis; Tobacco Smoking; Xenobiotics	2016
ssDNA-binding protein 2 is frequently hypermethylated and suppresses cell growth in human prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Jun-15, Volume: 14, Issue:12 Topics: Adenocarcinoma; Aged; Azacitidine; Base Sequence; Biomarkers, Tumor; Cell Cycle; Cell Proliferation; Decitabine; DNA Methylation; DNA Mutational Analysis; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Prostatic Hyperplasia; Prostatic Neoplasms; Tumor Cells, Cultured	2008
Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score. Urology, 2011, Volume: 77, Issue:4 Topics: A Kinase Anchor Proteins; Azacitidine; Cell Cycle Proteins; Cell Line, Tumor; Decitabine; DNA Methylation; DNA Modification Methylases; Humans; Male; Mitogens; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction	2011
EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jul-01, Volume: 17, Issue:13 Topics: Aged; Aged, 80 and over; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Epigenomics; Extracellular Matrix Proteins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Reproducibility of Results	2011
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells. Oncology reports, 2013, Volume: 29, Issue:3 Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinogenesis; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Epithelial Cells; Gene Expression; Glutathione S-Transferase pi; Humans; Male; Phenotype; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms	2013
Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer. Cancer science, 2003, Volume: 94, Issue:6 Topics: Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Male; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfites; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-1	2003
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer research, 2004, Sep-01, Volume: 64, Issue:17 Topics: Aged; Aged, 80 and over; Apoptosis; Azacitidine; Base Sequence; Cell Division; CpG Islands; Decitabine; Disease Progression; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, MDR; Humans; Male; Middle Aged; Molecular Sequence Data; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2004
Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Feb-01, Volume: 11, Issue:3 Topics: Aged; Aged, 80 and over; Azacitidine; Base Sequence; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Early Growth Response Protein 1; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucuronidase; Humans; Immediate-Early Proteins; Male; Middle Aged; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Transcription Factors; Up-Regulation	2005
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-15, Volume: 11, Issue:16 Topics: Aged; Antimetabolites, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Azacitidine; Cell Line, Tumor; Cytochrome P-450 CYP1B1; DNA Methylation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2005
Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Mar-01, Volume: 12, Issue:5 Topics: Acetylation; Adult; Aged; Aged, 80 and over; Azacitidine; Base Sequence; Blotting, Southern; Blotting, Western; Chromatin Immunoprecipitation; Decitabine; DNA Methylation; Down-Regulation; Enzyme Inhibitors; Gene Deletion; GTPase-Activating Proteins; Humans; Male; Middle Aged; Molecular Sequence Data; Promoter Regions, Genetic; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Proteins	2006
Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Molecular cancer, 2006, Jul-18, Volume: 5 Topics: Aged; Aged, 80 and over; Azacitidine; CARD Signaling Adaptor Proteins; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; Cytoskeletal Proteins; Decitabine; DNA Methylation; DNA Modification Methylases; DNA, Neoplasm; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Male; Middle Aged; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction	2006
Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer. Journal of molecular medicine (Berlin, Germany), 2006, Volume: 84, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Azacitidine; Cell Line, Tumor; Cell Transformation, Neoplastic; Cyclin D2; Cyclins; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic	2006
Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10 Topics: Adenocarcinoma; Animals; Azacitidine; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; Gene Expression Regulation, Neoplastic; Genes, p16; Genes, Retinoblastoma; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Prostatic Hyperplasia; Prostatic Neoplasms; Retinoblastoma Protein; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured	1997
Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:9 Topics: Adenocarcinoma; Antigens, CD; Azacitidine; Base Sequence; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Kangai-1 Protein; Male; Membrane Glycoproteins; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Proteins; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Proto-Oncogene Proteins; Sulfites; Tumor Cells, Cultured	2001
CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma. Cancer, 2001, Oct-15, Volume: 92, Issue:8 Topics: Azacitidine; Decitabine; DNA Methylation; DNA Modification Methylases; Estrogen Receptor beta; Gene Expression Regulation; Humans; Male; Neoplasms, Hormone-Dependent; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	2001